… inhibitors (TKIs), interferon alfa (IFNa) was the treatment of choice for patients with chronic myeloid leukemia (CML) who were not candidates for hematopoietic cell transplantation. IFNa is no longer the …
…patients receiving IFN-alfa plus ribavirin for hepatitis C virus infection. Recognition and risk factors are presented separately. Patients who are candidates for interferon-alfa (IFN-alfa) are often referred …
…those whose disease has progressed on initial immunotherapy-based regimens. The use of interferon alfa (IFNa) has largely been replaced by molecularly targeted agents and checkpoint inhibitor immunotherapy …
…the presence of interferon-alpha (IFN-alpha) in serum. Most patients have significant levels, whereas normal individuals have little or no circulating IFN-alpha . Furthermore, the IFN-alpha observed among …
…coincidental, and the evidence of a causal association is best for interferon alfa and tyrosine kinase inhibitors. The most common interferon alfa-associated thyroid abnormality is the development of de novo …